A closed and single-use system for monocyte enrichment: Potential for dendritic cell generation for clinical applications

Transfusion

Volumn 43, Issue 4, 2003, Pages 481-487

  Rouard, Helene ^a   Leon, Anne ^b   De Reys, Stef ^b   Taylor, Linda ^b   Logan, Josephine ^b   Marquet, Jeanine ^b   Jouault, Helene ^b   Loper, Kathy ^b   Maison, Patrick ^b   Delfau Larue, Marie Helene ^b   Beaujean, Françoise ^b   Farcet, Jean Pierre ^b   Noga, Stephen J ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; ARTICLE; CELL DENSITY; CELL DIFFERENTIATION; CELL ISOLATION; CELL SEPARATION; CELL SIZE; CONTROLLED STUDY; DENDRITIC CELL; DEVICE; FLOW CYTOMETRY; HUMAN; IMMUNOTHERAPY; IMPEDANCE; INTERMETHOD COMPARISON; LEUKOCYTE; MONOCYTE; MONONUCLEAR CELL; NORMAL HUMAN; THROMBOCYTE;

ANTIGENS, CD14; ANTIGENS, CD19; ANTIGENS, CD3; ANTIGENS, CD56; BLOOD COMPONENT REMOVAL; BLOOD PLATELETS; CELL COUNT; CELL DIFFERENTIATION; CELL SEPARATION; CELL SIZE; DENDRITIC CELLS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY; INTERLEUKIN-4; MONOCYTES;

EID: 0037390116     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00353.x     Document Type: Article

References (23)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
2. Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;2:52-8.
3. Caux C, Dezutter-Dambuyant C, Schmitt D, et al. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-61.
4. Reid CD, Stackpoole A, Meager A, et al. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol 1992;149:2681-8.
5. Mackensen A, Herbst B, Kohler G, et al. Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro. Blood 1995;86:2699-707.
6. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:83-93.
7. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-18.
8. Timmerman JM, Levy R. Dendritic cell vaccines for cancer immunotherapy. Annu Rev Med 1999;50:507-29.
9. Thurner B, Roder C, Dieckmann D, et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Meth 1999;223:1-15.
10. Bender A, Sapp M, Schuler G, et al. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Meth 1996;196:121-35.
11. Padley DJ, Dietz AB, Gastineau DA, et al. Mature myeloid dendritic cells for clinical use prepared from cd14+ cells isolated by immunomagnetic adsorption. J Hematother Stem Cell Res 2001;10:427-9.
12. Sanderson RJ, Shepperdson RT, Vatter AE, et al. Isolation and enumeration of peripheral blood monocytes. J Immunol 1977;118:1409-14.
13. Esa AH, Noga SJ, Donnenberg AD, et al. Immunological heterogeneity of human monocyte subsets prepared by counterflow centrifugation elutriation. Immunology 1986;59:95-9.
14. Rouard H, Leon A, Klonjkowski B, et al. Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity. J Immunol Meth 2000;241:69-81.
15. Stent G, Crowe SM. Effects of monocyte purification and culture on integrin expression. APMIS 1997;105:663-70.
16. Sato K, Nagayama H, Tadokoro K, et al. Interleukin-13 is involved in functional maturation of human peripheral blood monocyte-derived dendritic cells. Exp Hematol 1999;27:326-36.
17. Piemonti L, Bernasconi S, Luini W, et al. 1L-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. Eur Cytokine Netw 1995;6:245-52.
18. Nestle FO, Banchereau J, Hart D. Dendritic cells: on the move from bench to bedside. Nat Med 2001;7:761-5.
19. Pickl WF, Majdic O, Kohl P, et al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol 1996;157:3850-9.
20. Jonuleit H, Giesecke-Tuettenberg A, Tuting T, et al. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int J Cancer 2001;93:243-51.
21. Lau R, Wang F, Jeffery G, et al. Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma. J Immunother 2001;24:66-78.
22. Brossart P, Wirths S, Stuhler G, et al. Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 2000;96:3102-8.
23. Wong ECC, Lee SM, Aono F, et al. Comparison of elutriation with immunomagnetic selection to enrich monocytes for ex-vivo generation of dendritic cells (abstract). Blood 2000;96:779a.